Monarch Partners Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Monarch Partners Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$4M	Buy	186,706 +47,391	+34%	+$1.01M	1.18%	22
2022 Q3	$2.5M	Buy	139,315 +41,570	+43%	+$546K	0.75%	60
2022 Q2	$940K	Buy	97,745 +24,549	+34%	+$308K	0.26%	133
2022 Q1	$1.23M	Hold	73,196	–	–	0.28%	134
2021 Q4	$1.22M	Sell	73,196 -37,035	-34%	-$607K	0.25%	145
2021 Q3	$1.79M	Sell	110,231 -148,349	-57%	-$1.61M	0.26%	123
2021 Q2	$1.63M	Buy	258,580 +138,505	+115%	+$894K	0.23%	127
2021 Q1	$742K	Buy	120,075 +30,410	+34%	+$185K	0.11%	143
2020 Q4	$620K	Buy	+89,665	New	+$574K	0.11%	158

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Monarch Partners Asset Management's ISEE Position: Q4 2022 in Review

Monarch Partners Asset Management increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 34% in Q4 2022, buying an estimated $1.01M and bringing the position to 186,706 shares worth $4M. The position accounts for 1.18% of the portfolio, ranked #22.

Monarch Partners Asset Management first reported a position in ISEE in Q4 2020 and has held it in 9 quarters since. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

Monarch Partners Asset Management held 186,706 shares of IVERIC bio, Inc. Common Stock worth $4M as of Q4 2022.
Monarch Partners Asset Management bought 47,391 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $1.01M.
IVERIC bio, Inc. Common Stock made up 1.18% of Monarch Partners Asset Management's portfolio in Q4 2022, its #22 holding.
Monarch Partners Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and has held it in 9 quarters since.
225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Monarch Partners Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.